VITL, a personalised nutrition platform, has announced a £550k round of follow-on-funding, led by the Angel CoFund.
News Archive - November 2017
Investors have closely watched the outcome of the Patient Capital review, which could potentially unlock huge returns as slow-to-grow businesses are given time and support to mature. Angel CoFund investment director Tim Mills sees the fact that the government has taken consultation from the industry is a positive sign.
New investors included Angel CoFund and Richard Hargreaves, which will also join the intelligent robotic process automation business as a non-executive director.
OTCX, the fast-growing over-the-counter derivatives platform, is delighted to announce that it has received backing from the Angel CoFund as part of its latest funding round.